C.ANIRUDH JAGANNADH, M.SRAVANI and DR M.D DHANARAJU (2013) “ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA/GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS”, International Journal of Pharma and Bio Sciences, 4(2), pp. 750–754. Available at: https://ijpbs.net/index.php/journal/article/view/2225 (Accessed: 3 September 2026).